ORGANIC PHARMACY RESEARCH INSTITUTE INC
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2023 (Year End)
$879,259
Receivables (Non-Related)
56%
Cash & Equivalents
26%
Property, Plant, & Equipment (net)
12%
Investments
3%
Inventories
3%
Related-Party Receivables
0%
Prepaid Expenses
0%
Other Assets
0%
Liabilities in 2023 (Year End)
$23,249
Notes Payable / Debt (Non-Related)
64%
Payables & Accruals
36%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2022
2023
Change
Cash & Equivalents
$15,423
$224,523
+1356%
Receivables (Non-Related)
$80,100
$495,900
+519%
Related-Party Receivables
$0
$0
-
Inventories
$0
$25,000
-
Prepaid Expenses
$0
$0
-
Investments
$30,000
$30,000
+0%
Property, Plant, & Equipment (net)
$118,235
$103,836
-12%
Other Assets
$0
$0
-
Total Assets
$243,758
$879,259
+261%
Liabilities
2022
2023
Change
Payables & Accruals
$0
$8,380
-
Grants Payable
$0
$0
-
Deferred Revenue
$0
$0
-
Tax-Exempt Bond Liabilities
$0
$0
-
Custodial & Escrow Liabilities
$0
$0
-
Notes Payable / Debt (Non-Related)
$31,237
$14,869
-52%
Related-Party Payables
$0
$0
-
Other Liabilities
$5,334
$0
-100%
Total Liabilities
$36,571
$23,249
-36%
Net assets
2022
2023
Change
Restricted Net Assets
$0
$0
-
Unrestricted Net Assets
$207,187
$856,010
+313%
Net assets
2022
2023
Change
Net assets
+$207,187
+$856,010
+313%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)